Global Nintedanib Market Growth 2023-2029

March 2023 | 72 pages | ID: G53001CDB3FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Nintedanib Industry Forecast” looks at past sales and reviews total world Nintedanib sales in 2022, providing a comprehensive analysis by region and market sector of projected Nintedanib sales for 2023 through 2029. With Nintedanib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nintedanib industry.

This Insight Report provides a comprehensive analysis of the global Nintedanib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nintedanib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nintedanib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nintedanib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nintedanib.

The global Nintedanib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nintedanib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nintedanib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nintedanib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nintedanib players cover Boehringer Ingelheim Pharma. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Nintedanib market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 100mg*10 Capsules
• 150mg*10 Capsules
• 100mg*30 Capsules
• 150mg*30 Capsules
• 150mg*60 Capsules

Segmentation by application

• Locally Advanced NSCLC
• Variant NSCLC
• Locally Recurrent NSCLC

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Boehringer Ingelheim Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nintedanib market?

What factors are driving Nintedanib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nintedanib market opportunities vary by end market size?

How does Nintedanib break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nintedanib Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Nintedanib by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Nintedanib by Country/Region, 2018, 2022 & 2029
2.2 Nintedanib Segment by Type
  2.2.1 100mg*10 Capsules
  2.2.2 150mg*10 Capsules
  2.2.3 100mg*30 Capsules
  2.2.4 150mg*30 Capsules
  2.2.5 150mg*60 Capsules
2.3 Nintedanib Sales by Type
  2.3.1 Global Nintedanib Sales Market Share by Type (2018-2023)
  2.3.2 Global Nintedanib Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Nintedanib Sale Price by Type (2018-2023)
2.4 Nintedanib Segment by Application
  2.4.1 Locally Advanced NSCLC
  2.4.2 Variant NSCLC
  2.4.3 Locally Recurrent NSCLC
2.5 Nintedanib Sales by Application
  2.5.1 Global Nintedanib Sale Market Share by Application (2018-2023)
  2.5.2 Global Nintedanib Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Nintedanib Sale Price by Application (2018-2023)

3 GLOBAL NINTEDANIB BY COMPANY

3.1 Global Nintedanib Breakdown Data by Company
  3.1.1 Global Nintedanib Annual Sales by Company (2018-2023)
  3.1.2 Global Nintedanib Sales Market Share by Company (2018-2023)
3.2 Global Nintedanib Annual Revenue by Company (2018-2023)
  3.2.1 Global Nintedanib Revenue by Company (2018-2023)
  3.2.2 Global Nintedanib Revenue Market Share by Company (2018-2023)
3.3 Global Nintedanib Sale Price by Company
3.4 Key Manufacturers Nintedanib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nintedanib Product Location Distribution
  3.4.2 Players Nintedanib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION

4.1 World Historic Nintedanib Market Size by Geographic Region (2018-2023)
  4.1.1 Global Nintedanib Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Nintedanib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nintedanib Market Size by Country/Region (2018-2023)
  4.2.1 Global Nintedanib Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Nintedanib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nintedanib Sales Growth
4.4 APAC Nintedanib Sales Growth
4.5 Europe Nintedanib Sales Growth
4.6 Middle East & Africa Nintedanib Sales Growth

5 AMERICAS

5.1 Americas Nintedanib Sales by Country
  5.1.1 Americas Nintedanib Sales by Country (2018-2023)
  5.1.2 Americas Nintedanib Revenue by Country (2018-2023)
5.2 Americas Nintedanib Sales by Type
5.3 Americas Nintedanib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nintedanib Sales by Region
  6.1.1 APAC Nintedanib Sales by Region (2018-2023)
  6.1.2 APAC Nintedanib Revenue by Region (2018-2023)
6.2 APAC Nintedanib Sales by Type
6.3 APAC Nintedanib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nintedanib by Country
  7.1.1 Europe Nintedanib Sales by Country (2018-2023)
  7.1.2 Europe Nintedanib Revenue by Country (2018-2023)
7.2 Europe Nintedanib Sales by Type
7.3 Europe Nintedanib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nintedanib by Country
  8.1.1 Middle East & Africa Nintedanib Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Nintedanib Revenue by Country (2018-2023)
8.2 Middle East & Africa Nintedanib Sales by Type
8.3 Middle East & Africa Nintedanib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nintedanib
10.3 Manufacturing Process Analysis of Nintedanib
10.4 Industry Chain Structure of Nintedanib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nintedanib Distributors
11.3 Nintedanib Customer

12 WORLD FORECAST REVIEW FOR NINTEDANIB BY GEOGRAPHIC REGION

12.1 Global Nintedanib Market Size Forecast by Region
  12.1.1 Global Nintedanib Forecast by Region (2024-2029)
  12.1.2 Global Nintedanib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nintedanib Forecast by Type
12.7 Global Nintedanib Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Boehringer Ingelheim Pharma
  13.1.1 Boehringer Ingelheim Pharma Company Information
  13.1.2 Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
  13.1.3 Boehringer Ingelheim Pharma Nintedanib Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Boehringer Ingelheim Pharma Main Business Overview
  13.1.5 Boehringer Ingelheim Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nintedanib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nintedanib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg*10 Capsules
Table 4. Major Players of 150mg*10 Capsules
Table 5. Major Players of 100mg*30 Capsules
Table 6. Major Players of 150mg*30 Capsules
Table 7. Major Players of 150mg*60 Capsules
Table 8. Global Nintedanib Sales by Type (2018-2023) & (K Pcs)
Table 9. Global Nintedanib Sales Market Share by Type (2018-2023)
Table 10. Global Nintedanib Revenue by Type (2018-2023) & ($ million)
Table 11. Global Nintedanib Revenue Market Share by Type (2018-2023)
Table 12. Global Nintedanib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 13. Global Nintedanib Sales by Application (2018-2023) & (K Pcs)
Table 14. Global Nintedanib Sales Market Share by Application (2018-2023)
Table 15. Global Nintedanib Revenue by Application (2018-2023)
Table 16. Global Nintedanib Revenue Market Share by Application (2018-2023)
Table 17. Global Nintedanib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 18. Global Nintedanib Sales by Company (2018-2023) & (K Pcs)
Table 19. Global Nintedanib Sales Market Share by Company (2018-2023)
Table 20. Global Nintedanib Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Nintedanib Revenue Market Share by Company (2018-2023)
Table 22. Global Nintedanib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 23. Key Manufacturers Nintedanib Producing Area Distribution and Sales Area
Table 24. Players Nintedanib Products Offered
Table 25. Nintedanib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Nintedanib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 29. Global Nintedanib Sales Market Share Geographic Region (2018-2023)
Table 30. Global Nintedanib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Nintedanib Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Nintedanib Sales by Country/Region (2018-2023) & (K Pcs)
Table 33. Global Nintedanib Sales Market Share by Country/Region (2018-2023)
Table 34. Global Nintedanib Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Nintedanib Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Nintedanib Sales by Country (2018-2023) & (K Pcs)
Table 37. Americas Nintedanib Sales Market Share by Country (2018-2023)
Table 38. Americas Nintedanib Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Nintedanib Revenue Market Share by Country (2018-2023)
Table 40. Americas Nintedanib Sales by Type (2018-2023) & (K Pcs)
Table 41. Americas Nintedanib Sales by Application (2018-2023) & (K Pcs)
Table 42. APAC Nintedanib Sales by Region (2018-2023) & (K Pcs)
Table 43. APAC Nintedanib Sales Market Share by Region (2018-2023)
Table 44. APAC Nintedanib Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Nintedanib Revenue Market Share by Region (2018-2023)
Table 46. APAC Nintedanib Sales by Type (2018-2023) & (K Pcs)
Table 47. APAC Nintedanib Sales by Application (2018-2023) & (K Pcs)
Table 48. Europe Nintedanib Sales by Country (2018-2023) & (K Pcs)
Table 49. Europe Nintedanib Sales Market Share by Country (2018-2023)
Table 50. Europe Nintedanib Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Nintedanib Revenue Market Share by Country (2018-2023)
Table 52. Europe Nintedanib Sales by Type (2018-2023) & (K Pcs)
Table 53. Europe Nintedanib Sales by Application (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Nintedanib Sales by Country (2018-2023) & (K Pcs)
Table 55. Middle East & Africa Nintedanib Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Nintedanib Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Nintedanib Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Nintedanib Sales by Type (2018-2023) & (K Pcs)
Table 59. Middle East & Africa Nintedanib Sales by Application (2018-2023) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Nintedanib
Table 61. Key Market Challenges & Risks of Nintedanib
Table 62. Key Industry Trends of Nintedanib
Table 63. Nintedanib Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nintedanib Distributors List
Table 66. Nintedanib Customer List
Table 67. Global Nintedanib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 68. Global Nintedanib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Nintedanib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 70. Americas Nintedanib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Nintedanib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 72. APAC Nintedanib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Nintedanib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 74. Europe Nintedanib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Nintedanib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 76. Middle East & Africa Nintedanib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Nintedanib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 78. Global Nintedanib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Nintedanib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 80. Global Nintedanib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Boehringer Ingelheim Pharma Basic Information, Nintedanib Manufacturing Base, Sales Area and Its Competitors
Table 82. Boehringer Ingelheim Pharma Nintedanib Product Portfolios and Specifications
Table 83. Boehringer Ingelheim Pharma Nintedanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 84. Boehringer Ingelheim Pharma Main Business
Table 85. Boehringer Ingelheim Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nintedanib
Figure 2. Nintedanib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nintedanib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Nintedanib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nintedanib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg*10 Capsules
Figure 10. Product Picture of 150mg*10 Capsules
Figure 11. Product Picture of 100mg*30 Capsules
Figure 12. Product Picture of 150mg*30 Capsules
Figure 13. Product Picture of 150mg*60 Capsules
Figure 14. Global Nintedanib Sales Market Share by Type in 2022
Figure 15. Global Nintedanib Revenue Market Share by Type (2018-2023)
Figure 16. Nintedanib Consumed in Locally Advanced NSCLC
Figure 17. Global Nintedanib Market: Locally Advanced NSCLC (2018-2023) & (K Pcs)
Figure 18. Nintedanib Consumed in Variant NSCLC
Figure 19. Global Nintedanib Market: Variant NSCLC (2018-2023) & (K Pcs)
Figure 20. Nintedanib Consumed in Locally Recurrent NSCLC
Figure 21. Global Nintedanib Market: Locally Recurrent NSCLC (2018-2023) & (K Pcs)
Figure 22. Global Nintedanib Sales Market Share by Application (2022)
Figure 23. Global Nintedanib Revenue Market Share by Application in 2022
Figure 24. Nintedanib Sales Market by Company in 2022 (K Pcs)
Figure 25. Global Nintedanib Sales Market Share by Company in 2022
Figure 26. Nintedanib Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Nintedanib Revenue Market Share by Company in 2022
Figure 28. Global Nintedanib Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Nintedanib Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Nintedanib Sales 2018-2023 (K Pcs)
Figure 31. Americas Nintedanib Revenue 2018-2023 ($ Millions)
Figure 32. APAC Nintedanib Sales 2018-2023 (K Pcs)
Figure 33. APAC Nintedanib Revenue 2018-2023 ($ Millions)
Figure 34. Europe Nintedanib Sales 2018-2023 (K Pcs)
Figure 35. Europe Nintedanib Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Nintedanib Sales 2018-2023 (K Pcs)
Figure 37. Middle East & Africa Nintedanib Revenue 2018-2023 ($ Millions)
Figure 38. Americas Nintedanib Sales Market Share by Country in 2022
Figure 39. Americas Nintedanib Revenue Market Share by Country in 2022
Figure 40. Americas Nintedanib Sales Market Share by Type (2018-2023)
Figure 41. Americas Nintedanib Sales Market Share by Application (2018-2023)
Figure 42. United States Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Nintedanib Sales Market Share by Region in 2022
Figure 47. APAC Nintedanib Revenue Market Share by Regions in 2022
Figure 48. APAC Nintedanib Sales Market Share by Type (2018-2023)
Figure 49. APAC Nintedanib Sales Market Share by Application (2018-2023)
Figure 50. China Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Nintedanib Sales Market Share by Country in 2022
Figure 58. Europe Nintedanib Revenue Market Share by Country in 2022
Figure 59. Europe Nintedanib Sales Market Share by Type (2018-2023)
Figure 60. Europe Nintedanib Sales Market Share by Application (2018-2023)
Figure 61. Germany Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Nintedanib Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Nintedanib Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Nintedanib Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Nintedanib Sales Market Share by Application (2018-2023)
Figure 70. Egypt Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Nintedanib Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Nintedanib in 2022
Figure 76. Manufacturing Process Analysis of Nintedanib
Figure 77. Industry Chain Structure of Nintedanib
Figure 78. Channels of Distribution
Figure 79. Global Nintedanib Sales Market Forecast by Region (2024-2029)
Figure 80. Global Nintedanib Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Nintedanib Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Nintedanib Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Nintedanib Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Nintedanib Revenue Market Share Forecast by Application (2024-2029)